FDA.reportPublic FDA data

Ceftazidime

Product NDC
44567-235
11-digit product format
445670235
Labeler code
44567
Product ID
44567-235_c1a9149a-efde-4f1c-a5f9-72a369d72c0e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ceftazidime
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
WG Critical Care, LLC
Application
ANDA062640
Marketing category
ANDA
Marketing start
2013-01-31
Substance
CEFTAZIDIME
Active strength
1 g/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ceftazidime
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFTAZIDIME1 g/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9M416Z9QNR
Rxcui1659283, 1659287

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5Product name120150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
44567-235-25Ceftazidime25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION2510
44567-235-25Ceftazidime1 in 1 VIALINJECTION, POWDER, FOR SOLUTION110

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
44567-235-25EA - Each44567-2354b44fc23-e0f8-4b1b-b471-fd1dc1901b7f12013-08-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CEFTAZIDIMEACTIVE INGREDIENT9M416Z9QNRCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]2
CEFTAZIDIME ANHYDROUSACTIVE MOIETYDZR1ENT301CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
44567-235CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC]10Current NDC, Legacy NDC, 2 package rows20240201_bcc81df2-20e3-4738-bfcf-301da883c1d9.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1659283cefTAZidime 1 GM InjectionPSNbcc81df2-20e3-4738-bfcf-301da883c1d910
1659287cefTAZidime 2 GM InjectionPSNbcc81df2-20e3-4738-bfcf-301da883c1d910
1659283ceftazidime 1000 MG InjectionSCDbcc81df2-20e3-4738-bfcf-301da883c1d910
1659287ceftazidime 2000 MG InjectionSCDbcc81df2-20e3-4738-bfcf-301da883c1d910
1659283ceftazidime (as ceftazidime pentahydrate) 1000 MG InjectionSYbcc81df2-20e3-4738-bfcf-301da883c1d910
1659287ceftazidime (as ceftazidime pentahydrate) 2000 MG InjectionSYbcc81df2-20e3-4738-bfcf-301da883c1d910
1659283ceftazidime 1 GM InjectionSYbcc81df2-20e3-4738-bfcf-301da883c1d910
1659287ceftazidime 2 GM InjectionSYbcc81df2-20e3-4738-bfcf-301da883c1d910

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
44567-235-254456702352525 VIAL in 1 CARTON (44567-235-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL25 vial2013-01-310000-00-00NoNoCurrent